Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Renal cell carcinoma.

R E Cronin1

  • 1University of Texas Southwestern Medical Center, Dallas.

The American Journal of the Medical Sciences
|October 1, 1991
PubMed
Summary
This summary is machine-generated.

Renal cell carcinoma is a rare cancer with unique traits. It often affects patients with acquired renal cystic disease, particularly those on chronic hemodialysis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gentamicin causes endocytosis of Na/Pi cotransporter protein (NaPi-2).

Kidney international·2001
Same author

Dexamethasone modulates rat renal brush border membrane phosphate transporter mRNA and protein abundance and glycosphingolipid composition.

The Journal of clinical investigation·1995
Same author

Heterogeneity in gentamicin clearance between high-efficiency hemodialyzers.

American journal of kidney diseases : the official journal of the National Kidney Foundation·1994
Same author

Southwestern Internal Medicine Conference: bone disease in kidney failure: diagnosis and management.

The American journal of the medical sciences·1993
Same author

A comparison of netilmicin and tobramycin therapy in patients with renal impairment.

Scandinavian journal of infectious diseases·1992
Same author

Role of potassium in the pathogenesis of acute renal failure.

Mineral and electrolyte metabolism·1991
Same journal

Providers' Perspectives on Hospital-Based Tobacco Treatment Efforts.

The American journal of the medical sciences·2026
Same journal

In Memoriam: Maurice A. Mufson, MD, MACP.

The American journal of the medical sciences·2026
Same journal

Outcomes of acute myeloid leukemia patients admitted to the intensive care unit within 100 days of allogeneic hematopoietic stem cell transplantation.

The American journal of the medical sciences·2026
Same journal

Association Between Reverse Triiodothyronine and Cardiac Complications in Patients with Uncontrolled Graves' Disease.

The American journal of the medical sciences·2026
Same journal

Chlorthalidone vs. hydrochlorothiazide in hypertension management: Lessons for guiding clinical practice.

The American journal of the medical sciences·2026
Same journal

The impact of COVID-19 on alcohol-associated hepatitis and alcohol-associated cirrhosis.

The American journal of the medical sciences·2026
See all related articles

Area of Science:

  • Oncology
  • Nephrology

Background:

  • Renal cell carcinoma (RCC) represents 3% of adult malignancies.
  • RCC exhibits distinctive clinical and diagnostic characteristics.
  • Acquired renal cystic disease (ARCD) is strongly associated with RCC, predominantly in chronic hemodialysis patients.

Observation:

  • ARCD, a condition common in chronic hemodialysis patients, is linked to RCC development.
  • Chromosome 3 abnormalities are recurrent in both sporadic and familial RCC cases.

Findings:

  • The study highlights the unusual presentation, diagnosis, and management of renal cell carcinoma.
  • A significant association exists between acquired renal cystic disease in hemodialysis patients and the development of RCC.
  • Frequent chromosomal abnormalities involving chromosome 3 are noted in various forms of RCC.

Related Experiment Videos

Implications:

  • Understanding the link between ARCD and RCC may improve early detection in hemodialysis patients.
  • Further research into chromosome 3 abnormalities could reveal novel therapeutic targets for RCC.
  • Radical nephrectomy is currently the sole potentially curative treatment option for renal cell carcinoma.